Substance group according to site of action | Chemical name | Non-allergic intolerance | Immediate-type reaction | Uncomplicated rash | Hypersensitivity syndrome | Bullous skin reaction | Cytopenia | Other |
---|---|---|---|---|---|---|---|---|
Cyclooxygenase inhibitors | ASA and NSAID | frequent | – | rare | – | rare | – | rare |
P2Y12 inhibitors | Thienopyridine/ticagrelor | – | rare | occasional | rare | isolated | – | rare |
Glycoprotein IIb/IIIa receptor antagonists | Fibans/abciximab | – | rare | isolated | – | – | frequent | – |
Phosphodiesterase inhibitors/dipyridamole | Quinolinone derivative/dipyridamole | –/– | -/rare | –/isolated | isolated/– | isolated/isolated | –/– | –/– |
Vitamin K antagonists | Coumarins | – | isolated | rare | – | isolated | – | isolated |
Antithrombin-III activators (heparins) | Glycosaminoglycans | – | isolated | frequent | – | rare | – | occasional |
Direct factor Xa inhibitors | Xabans, oxazolidinones | – | iolated | rare | – | – | – | isolated |
Direct thrombin inhibitors | bivalent polypeptide hirudin derivatives, nonpeptide thrombin inhibitors | – | – | rare | – | isolated | – | – |
No data given (–): insufficient information available